Close

Rosetta Genomics (ROSG) Study Published in Urologic Oncology

January 16, 2014 8:24 AM EST Send to a Friend
Rosetta Genomics Ltd. (NASDAQ: ROSG) announces the publication of clinical data in the online edition of Urologic Oncology: Seminars and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login